Common Contracts
1 similar Common Stock Sales Agreement contracts
PROSPECTUS SUPPLEMENT Filed Pursuant to Rule 424(b)(5)Common Stock Sales Agreement • October 11th, 2022 • New York
Capricor Therapeutics, Inc. has entered into a Common Stock Sales Agreement, or the Sales Agreement, with H.C. Wainwright & Co. LLC, or Wainwright, relating to the sale of shares of our common stock, par value $0.001 per share, offered by this prospectus supplement. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock from time to time through Wainwright acting as agent, subject to the limitations contained in the Sales Agreement. This prospectus supplement relates to the sale of shares of our common stock under the Sales Agreement with an aggregate offering price of up to $75,000,000.
